產(chǎn)品名稱 | 磷酸化胞漿型磷脂酶A2抗體 |
英文名稱 | Anti-phospho-CPLA2 (Ser505) |
規(guī)格 | 0.1ml/100μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-phospho-CPLA2 (Ser505)
中文名稱 磷酸化胞漿型磷脂酶A2抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Horse, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子
蛋白分子量 predicted molecular weight: 82kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthesised phosphopeptide derivedfrom human CPLA2 around the phosphorylation site of Ser505 [PL(p-S)PL]
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -429 °C for oneyear.
別 名 CPLA2(phospho-Ser505); CPLA2(phospho-S505); p-CPLA2(Ser505); p-CPLA2 (S505); Calcium dependent phospholipid binding protein; CPLA2; cPLA2 alpha; cPLA2; Cytosolic phospholipase A2; Cytosolic phospholipase A2group IVA; Lysophospholipase; MGC126350; PA24A_HUMAN; Phosphatidylcholine 2acylhydrolase; Phosphatidylcholine 2-acylhydrolase; Phospholipase A2 group 4 A;Phospholipase A2 group IVA (cytosolic calcium dependent); Phospholipase A2group IVA; PhospholipaseA2; PLA2G4.
